BAWAG Group AG (0RVE)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 164.20 |
|---|---|
| 52-week range | 102.40 – 185.00 |
| Return, 1 month / 3 months | −7.9% / −4.8% |
| Return, 1 year / 3 years | +49.4% / +335.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -15.4% |
| Average daily value traded | 2.91M EUR |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BAWAG Group is an Austrian bank based in Vienna that provides retail and commercial banking services. It offers savings accounts, mortgages, consumer loans and credit products to private customers, and lends to small and medium-sized businesses as well as larger corporate clients. The bank also provides investment and insurance products and operates mainly in Austria and Germany, with additional activities in other European markets.
BAWAG Group AG trades under the code 0RVE on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BAWAG Group AG (0RVE) trades on the London Exchange in UK. It last closed at EUR 164.20 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 633 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 49.4% and over the last three months it fell 4.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.1% | ||
| From 52-week high | -10.4% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.8% | ||
| 6-month return | 9.7% | ||
| 12-month return, skipping the last month | 62.3% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.4% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.91M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | −7.9% |
| 3 months | −4.8% |
| 6 months | +9.7% |
| 1 year | +49.4% |
| 3 years | +335.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 176.57 / 154.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | EUR 2.2000 |
| 8 Apr 2025 | EUR 5.5000 |
| 10 Apr 2024 | EUR 5.0000 |
| 4 Apr 2023 | EUR 3.7000 |
| 1 Apr 2022 | EUR 3.0000 |
| 6 Oct 2021 | EUR 4.7218 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.